Woodline Partners LP Cara Therapeutics, Inc. Transaction History
Woodline Partners LP
- $9.97 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding CARA
# of Institutions
88Shares Held
16.5MCall Options Held
55KPut Options Held
500-
Vanguard Group Inc Valley Forge, PA2.25MShares$675,1000.0% of portfolio
-
Disciplined Growth Investors Inc Minneapolis, MN1.94MShares$580,7150.01% of portfolio
-
Chescapmanager LLC Baltimore, MD1.7MShares$510,6330.04% of portfolio
-
Farallon Capital Management LLC San Francisco, CA1.56MShares$466,8750.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.07MShares$319,7250.0% of portfolio
About Cara Therapeutics, Inc.
- Ticker CARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,725,900
- Market Cap $16.1M
- Description
- Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...